| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |